Enliven Therapeutics Current Assets

Enliven Therapeutics (ELVN) currently reports a current assets of $910M as of June 2026. That compares with $500M in the prior-year period — up 83.1% year over year. Use the charts on this page to explore Enliven Therapeutics's current assets history and peer comparisons.

Enliven Therapeutics's current assets increased from $500M to $910M — a 83.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Enliven Therapeutics reported $910M in current assets as of June 2026. That compares with $500M in the prior-year period — up 83.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $910M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Enliven Therapeutics, and consider following ELVN for alerts when major investors trade the stock.

Enliven Therapeutics is classified in the Healthcare sector. On current assets, it currently shows $910M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ELVN with unrelated industries.